Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Grootendorst

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Annals of Emergency Medicine|July 19, 2015
Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency DepartmentsKathy Boutis, Camilla von Keyserlingk, Andrew Willan, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Economic evaluation of vaccines in Canada: A systematic reviewAyman Chit, Jason K H Lee, Minsup Shim, et al.
Biopharmaceutics & Drug Disposition|July 5, 2021
Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β-amyloid peptide accumulation in miceH Benson Peng, Paola Bukuroshi, Matthew R Durk, et al.
Journal of the American Pharmacists Association : Japha|May 1, 2021
Impact of a peer comparison intervention on seasonal influenza vaccine uptake in community pharmacy: A national cluster randomized studyMatthew M Loiacono, Christopher B Nelson, Paul Grootendorst, et al.
CMAJ Open|August 1, 2014
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysisClaire de Oliveira, Hai V Nguyen, Harindra C Wijeysundera, et al.
The Canadian Journal of Cardiology|December 11, 2012
Canada's contribution to global research in cardiovascular diseasesHai V Nguyen, Claire de Oliveira, Harindra C Wijeysundera, et al.
Health Policy (Amsterdam, Netherlands)|June 16, 2007
The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from CanadaDeborah A Marshall, Donald J Willison, Paul Grootendorst, et al.
Vaccine: X|February 20, 2020
Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort studyMatthew M Loiacono, Salaheddin M Mahmud, Ayman Chit, et al.
BMJ Open|November 14, 2019
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis updateAysegul Erman, Murray D Krahn, Tawnya Hansen, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2025
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD CountriesAlexander C T Tam, Jasleen Badesha, Daphne P Guh, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Annals of Emergency Medicine|July 19, 2015
Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency DepartmentsKathy Boutis, Camilla von Keyserlingk, Andrew Willan, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Economic evaluation of vaccines in Canada: A systematic reviewAyman Chit, Jason K H Lee, Minsup Shim, et al.
Biopharmaceutics & Drug Disposition|July 5, 2021
Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β-amyloid peptide accumulation in miceH Benson Peng, Paola Bukuroshi, Matthew R Durk, et al.
Journal of the American Pharmacists Association : Japha|May 1, 2021
Impact of a peer comparison intervention on seasonal influenza vaccine uptake in community pharmacy: A national cluster randomized studyMatthew M Loiacono, Christopher B Nelson, Paul Grootendorst, et al.
CMAJ Open|August 1, 2014
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysisClaire de Oliveira, Hai V Nguyen, Harindra C Wijeysundera, et al.
The Canadian Journal of Cardiology|December 11, 2012
Canada's contribution to global research in cardiovascular diseasesHai V Nguyen, Claire de Oliveira, Harindra C Wijeysundera, et al.
Health Policy (Amsterdam, Netherlands)|June 16, 2007
The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from CanadaDeborah A Marshall, Donald J Willison, Paul Grootendorst, et al.
Vaccine: X|February 20, 2020
Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort studyMatthew M Loiacono, Salaheddin M Mahmud, Ayman Chit, et al.
BMJ Open|November 14, 2019
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis updateAysegul Erman, Murray D Krahn, Tawnya Hansen, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2025
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD CountriesAlexander C T Tam, Jasleen Badesha, Daphne P Guh, et al.
Pageof 8